Cohera Medical, Inc.
5909 Steele Road
Murrysville
Pennsylvania
15668
United States
79 articles about Cohera Medical, Inc.
-
Significant Advance in Breast Cancer Care – Cohera Medical Drain-Free Mastectomy Trial Reaches Full Enrollment
10/17/2017
11 breast centers in the UK and Germany complete enrollment of a clinical study comparing mastectomy flap closure using TissuGlu without surgical drains vs. standard of care with drain.
-
Cohera Medical Announces Exclusive Distribution Agreement For Cohera’s Sylys Surgical Sealant In Japan
9/6/2017
-
Cohera Medical Release: Multiple Postmarket Clinical Studies Nearing Completion In Europe, Supporting Broad Range Of Applications For TissuGlu Surgical Adhesive
8/15/2017
-
Cohera Medical Release: Tissuglu Surgical Adhesive Facilitates Drain-Free Mastectomy
7/12/2017
-
Cohera Medical Release: Tissuglu Surgical Adhesive Enables Drain-Free Recovery In Patients Undergoing DIEP Flap Breast Reconstruction
6/8/2017
-
Cohera Medical Release: Drain-Free Mastectomy With TissuGlu Surgical Adhesive Presented At UK Breast Surgery Meeting
5/24/2017
-
Dr. Michelle Spring Of Glacier View Plastic Surgery Completes Enrollment In A Clinical Comparison Of Tissuglu Surgical Adhesive (Cohera Medical ) Vs. Progressive Tension Suture Technique
4/26/2017
-
Executive-Level Specialty Medical And Biopharmaceutical Sales Management Professional Joins Cohera Medical
2/22/2017
-
Cohera Medical Appoints Paul Thomas To Its Board Of Directors
7/25/2016
-
Cohera Medical Signs Huge Lease in Raleigh, Will Relocate 70% of Staff
2/4/2016
-
Investors Pump $50 Million into Cohera Medical
10/23/2015
-
Cohera Medical, Inc. Receives CE Marking Approval For Sylys Surgical Sealant
8/13/2015
-
Cohera Medical, Inc. Receives Expedited Access Pathway Designation From FDA For SylysSurgical Sealant
6/9/2015
-
FDA Approves Cohera Medical, Inc.'s First-Ever Tissue Adhesive for Use in Surgery
2/5/2015
-
Cohera Medical, Inc. Enters Agreement With B. Braun Surgical, S.A. For Distribution Of Tissuglu® Surgical Adhesive In Select European Countries
1/21/2015
-
Cohera Medical, Inc. Receives PMA Approvable Letter From U.S. FDA For TissuGlu® Surgical Adhesive
1/6/2015
-
Cohera Medical, Inc. Receives Priority Review Status Designation From FDA For Sylys Surgical Sealant
12/17/2014
-
Cohera Medical, Inc. Submits Investigational Device Exemption To FDA For Clinical Trial Of Its Sylys Surgical Sealant
12/9/2014
-
Cohera Medical, Inc. Awarded Patent For Breakthrough Pressure Sensitive Adhesive Technology
12/2/2014
-
Cohera Medical, Inc.'s TissuGlu® Surgical Adhesive Wins Approval For 18 Month Shelf Life in Europe
9/10/2014